Related Experiment Video

Updated: May 9, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Management algorithm for genotype 1 hepatitis C virus

Arthur Y Kim1

  • 1Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School Boston, Massachusetts 02114 USA.

F1000Prime Reports
|July 19, 2013
PubMed

Insights

Hepatitis C virus (HCV) infection management is improving with new therapies. This guide offers a framework for clinicians treating HCV genotype 1, addressing knowledge gaps for better patient outcomes.

Area of Science:

  • Hepatology and Viral Gastroenterology
  • Clinical Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease globally.
  • Increasing morbidity and mortality associated with HCV-related end-stage liver disease.
  • Emergence of novel therapeutics offers improved cure rates but faces implementation challenges.

Purpose of the Study:

  • To provide a management framework for Hepatitis C virus (HCV) genotype 1 infection.
  • To address the deficit in provider knowledge regarding novel HCV therapeutics.
  • To guide initial clinical decisions for the most common HCV genotype.

Main Methods:

  • Development of a general framework and clinical algorithms.
  • Focus on therapies approved as of 2013 for HCV genotype 1.
  • Guidance for initial management decisions.

Main Results:

  • Provides a structured approach to managing HCV genotype 1.
  • Aims to bridge the knowledge gap among healthcare providers.
  • Facilitates the effective application of new HCV treatments.

Conclusions:

  • Effective management of HCV genotype 1 requires updated provider knowledge.
  • Algorithmic guidance can support the optimal use of novel HCV therapies.
  • Addressing provider education is crucial for mitigating HCV-related liver disease.

More Related Videos

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants15:49

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...